TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C.

Mark H O'Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.